Mr Marco Mochi Italy

BMG PHARMA SPA
Director Business Development 

Mr Holger Neecke Italy

Adare Pharmaceutical Technologies (PT) is the specialty CDMO business unit of Adare, a global specialty pharmaceutical company. A science-driven provider of dosage form solutions for the healthcare industry – with expertise in taste masking and customized drug release – Adare PT is a leading partner to pharmaceutical companies across branded, specialty, 505b2, generic and OTC segments. With over 30 years of proven legacy, Adare PT focuses on oral dosage forms for small molecules across all therapeutic areas. To learn more, email us at BusDevROW@adarepharma.com.

Mr Holger Neecke
Adare Pharmaceuticals
Director, Business Development 

Francesca Orsini Italy


Indena is the leading company dedicated to the identification, development and production of high quality active principles derived from plants, for use in the pharmaceutical, health-food and personal care industries, complying with the most strict regulations. Backed up by over 90 years of botanical experience, the company has more than 120 primary patents, has published more than 700 scientific studies and co-operates with the world’s most prestigious universities and private research institutions. Headquartered in Milan, Indena has 5 production sites and 5 international branches throughout the world and manages sales in more than 70 countries.


In the supplements’ field, Indena has developed a collection of products, containing clinically validated botanical actives for a variety of health needs, ranging from the CV to the joint health field, from metabolism to the gut health sector. These ready-to-market final formulations have been designed and developed to maximize the performance of the active ingredients and to guarantee their quality and stability over time. All proposed formulations can be tailored to fulfill specific regulatory or customer requirements.
 
 

Website:
www.indena.com
Indena S.p.A
BD&licensing manager 

Mr Paul Phull Italy

BMG Pharma is involved in the development of new healthcare products in the areas of oral care, dermatology including aesthetics, anaemia, osteoarthritis & cancer supportive care.

The company has created a strong portfolio of intellectual property which it has developed into a number of products that have been partnered with companies around the world.

The company recently merged with Sigea,an Italian company with expertise in targeted functional ingredients development currently focused on modified sodium hyaluronate for application in a number of therapeutic areas including dermatology and oral care. This merger will allow BMG to accelerate the development of a number of new products to complement its portfolio.

Mr Paul Phull
BMG PHARMA SPA
COO 

Dr Marcello Pizzullo Italy

Aboca Group
Head of Business Development & Licensing 

Mrs Claudia Rinaldi Italy

PETRONE GROUP is a privately-owned family company operating in the pharmaceutical, parapharmaceutical and health sector since 1965, with the main offices in Italy and branches in Spain, Singapore and Ireland.

The Group provides a wide range of warehousing, world-wide distribution services.

 Pharmaidea is a partner of excellence for pharmaceutical companies that want to increase their value in pharmacy retail market in Italy and Spain, through tailor-made  business models  through a multi-channel approach directed to different targets measurable by PharmaCo through shared KPIs.

Thanks to the Euromed division, our company ensures an efficient and timely distribution of authorized orphan drugs and unlicensed products on “order to cash” basis all over Europe in order to facilitate patients’ access to innovative drug treatments as early as possible.

We offer customized and full-integrated logistic services also for the management of “restricted and controlled” drugs and cold chain products. These services include the manufacture of primary and secondary packaging, warehouse storage, labelling and shipping, and product recall along with authorized destruction procedures (STM division).

Our company is also specialized in Global Comparator Sourcing and IMP Management for international clinical trials: Euromed Clinical Supply Services (Eclisse division) is GCP-compliant and provides IMP Production services in accordance with EU-GMP/CGMP legal requirements.

Our Group is listed in SPAIN (BCN Farma division) as Authorized to manage Medicamentos Especiales while in IRELAND we currently hold the GMP certification to Store unauthorized European and non- European drugs.

 

Website:
www.petrone.it
Petrone Group
LinkedIn logo Corporate Business Development 

Mr GABRIELE SCALI Italy

Website:
www.abiogen.it
ABIOGEN PHARMA SPA
DIRECTOR OF LICENSING & BUSINESS DEVELOPMENT AND INTELLIGENCE 

Elena Tommesani Italy

CHIESI FARMACEUTICI SPA
Head of BD& Licensing - Chiesi Italy